PCM
OCDX

Prelude Capital Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Prelude Capital Management’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-175,947
Closed -$3.28M – 2256
2022
Q1 		$3.28M Buy
+175,947
New +$3.17M 0.09% 201

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Prelude Capital Management's OCDX Position: Q2 2022 in Review

Prelude Capital Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 175,947 shares — an estimated $3.28M sold.

Prelude Capital Management first reported a position in OCDX in Q1 2022 and held it in 1 quarter. The position peaked at $3.28M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Prelude Capital Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Prelude Capital Management sold 175,947 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $3.28M.
  • Prelude Capital Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2022 and held it in 1 quarter.
  • Prelude Capital Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $3.28M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Prelude Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.